Zumutor Biologics, a biotechnology startup in the immuno-oncology space, has raised $4 million in fresh funding from the Bharat Innovation Fund and Accel Partners, bringing its total funding to $20 million so far. The company said the capital will be used for the process of new drug filing of its lead molecule(ZM 008) in India, and to go through the first phase of clinical trials by the end of 2020.